Senseonics Announces the First Pediatric Study Participant Insertions in the ENHANCE Clinical Trial

Source :: Business Wire. April 18, 2023
Publication Year :: 2023
Abstract: GERMANTOWN, Md. -- Senseonics Holdings, Inc. (NYSE-American: SENS), a medical technology company focused on the development and manufacturing of long-term, implantable continuous glucose monitoring (CGM) systems for people with diabetes, [...]

Subjects :: Tetracycline -- Research
Medical research
Medicine, Experimental
High technology industry -- Research
Clinical trials -- Research
Children -- Health aspects
Prediabetic state -- Research
Blood sugar monitoring -- Research
Tetracyclines -- Research
Diabetics -- Research
Type 2 diabetes -- Research
Business
Business, international

Tools